DEVELOPMENT AND EVALUATION OF SBA-15 MESOPOROUS SILICA NANOPARTICLES FOR BIOAVAILABILITY ENHANCEMENT OF RITONAVIR. Int. Res. J. Pharm. [Internet]. 2018 Mar. 3 [cited 2026 Nov. 2];9(3):13-9. Available from: https://irjponline.org/index.php/irjp/article/view/808